Docusign Inc. (NASDAQ:DOCU) Short Interest Up 33.1% in March

16 Apr 2026, 19:56 by Scott Moore · The Cerbat Gem

Docusign Inc. (NASDAQ:DOCU – Get Free Report) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 18,154,041 shares, a growth of 33.1% from the March 15th total of 13,642,829 shares. Based on an average daily volume of 6,117,449 shares, the short-interest ratio is currently 3.0 days. Currently, 9.4% of the shares of the stock are short sold.

Docusign Price Performance

NASDAQ DOCU traded down $0.78 on Thursday, reaching $46.06. The company had a trading volume of 3,437,915 shares, compared to its average volume of 4,899,759. The firm has a market cap of $8.96 billion, a price-to-earnings ratio of 31.12, a P/E/G ratio of 1.70 and a beta of 0.99. Docusign has a fifty-two week low of $40.16 and a fifty-two week high of $94.67. The business has a 50 day moving average of $46.34 and a two-hundred day moving average of $59.49.

Docusign (NASDAQ:DOCU – Get Free Report) last posted its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.06. The business had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.Docusign’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.86 earnings per share. As a group, research analysts predict that Docusign will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its Board of Directors has approved a share buyback plan on Tuesday, March 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 21% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.

Analyst Ratings Changes

DOCU has been the subject of a number of research reports. Weiss Ratings cut Docusign from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday. Jefferies Financial Group cut Docusign from a “buy” rating to a “hold” rating and dropped their price target for the company from $105.00 to $45.00 in a research note on Monday, February 23rd. Bank of America initiated coverage on Docusign in a research note on Tuesday, March 31st. They issued an “underperform” rating and a $52.00 price target for the company. UBS Group dropped their price target on Docusign from $75.00 to $54.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Finally, Cantor Fitzgerald reiterated an “outperform” rating on shares of Docusign in a research note on Wednesday, December 17th. Four equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $61.40.

Read Our Latest Report on Docusign

Insider Buying and Selling

In related news, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $46.84, for a total value of $281,040.00. Following the transaction, the executive owned 79,233 shares in the company, valued at approximately $3,711,273.72. This trade represents a 7.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mary Agnes Wilderotter sold 3,000 shares of the firm’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $48.15, for a total value of $144,450.00. Following the completion of the transaction, the director owned 59,803 shares in the company, valued at $2,879,514.45. The trade was a 4.78% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 64,673 shares of company stock valued at $3,077,699 in the last ninety days. Insiders own 1.01% of the company’s stock.

Institutional Trading of Docusign

Institutional investors have recently bought and sold shares of the company. Central Pacific Bank Trust Division bought a new stake in shares of Docusign during the fourth quarter worth about $25,000. Modus Advisors LLC bought a new stake in shares of Docusign during the fourth quarter worth about $27,000. Torren Management LLC bought a new stake in shares of Docusign during the fourth quarter worth about $28,000. True Wealth Design LLC increased its position in shares of Docusign by 105.2% during the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after acquiring an additional 222 shares in the last quarter. Finally, Aventura Private Wealth LLC bought a new stake in shares of Docusign during the fourth quarter worth about $30,000. Institutional investors own 77.64% of the company’s stock.

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.